[ U.S. DEPARTMENT OF DEFENSE - Duchenne Muscular Dystrophy Career Development Award | Research Funding ]
Event details
| Date | 14.11.2018 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Duchenne Muscular Dystrophy Research Program (DMDRP) for 2018. The DMDRP Career Development Award mechanism supports early-career investigators in conducting impactful Duchenne research under the mentorship of an experienced muscular dystrophy researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of Duchenne research. Applicants should also demonstrate that the proposed research has high potential to lead to or make breakthroughs in Duchenne.
The proposed research must address at least one of the FY18 DMDRP Focus Areas. The Focus Areas are listed at the end of this announcement.
Funding: Maximum USD $ 275’000
Duration: 2 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The PI must be an independent, early-career researcher at least 2 years past their terminal degree. The Mentor must hold a position at or above the level of an Associate Professor, and must be an experienced muscular dystrophy researcher as demonstrated by a strong record of funding and publications in muscular dystrophy research.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a letter of intent, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 14 November 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 05 December 2018, 11:59 p.m. EST (05:59 06 Dec, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-DMDRP-CDA
Further information
FY18 DMDRP Focus Areas
The proposed research must address at least one of the FY18 DMDRP Focus Areas. The Focus Areas are listed at the end of this announcement.
Funding: Maximum USD $ 275’000
Duration: 2 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The PI must be an independent, early-career researcher at least 2 years past their terminal degree. The Mentor must hold a position at or above the level of an Associate Professor, and must be an experienced muscular dystrophy researcher as demonstrated by a strong record of funding and publications in muscular dystrophy research.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a letter of intent, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 14 November 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 05 December 2018, 11:59 p.m. EST (05:59 06 Dec, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-DMDRP-CDA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-18-DMDRP-CDA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY18 DMDRP Focus Areas
- Bone, cardiac, central nervous system (CNS), and/or gastrointestinal tract studies, including identifying mechanisms of pathology and therapeutic interventions
- Translational and clinical studies, novel interventions, and drug and biologic delivery technologies designed to improve care and quality of life
- Assessment of clinical trial tools and outcome measures
- Extension or expansion of existing preclinical translational data in support of a specific therapeutic development path
Practical information
- General public
- Free